Bellwether Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
6,646
-3,294
-33% -$685K 0.23% 78
2026
Q1
$2.1M Buy
+9,940
New +$2.14M 0.36% 66
2025
Q3
Sell
-299
Closed -$50.2K 202
2025
Q2
$50.2K Sell
299
-9,665
-97% -$1.43M 0.01% 222
2025
Q1
$1.37M Buy
9,964
+9,696
+3,618% +$1.24M 0.29% 56
2024
Q4
$31.7K Buy
+268
New +$31.3K 0.01% 258
2024
Q3
Sell
-24,573
Closed -$2.42M 127
2024
Q2
$2.42M Sell
24,573
-31,388
-56% -$3.2M 0.51% 50
2024
Q1
$6.26M Sell
55,961
-6,438
-10% -$695K 1.38% 17
2023
Q4
$6.29M Buy
+62,399
New +$6.19M 1.55% 17
2023
Q2
Sell
-31,868
Closed -$2.41M 140
2023
Q1
$2.41M Buy
31,868
+10,253
+47% +$774K 0.66% 36
2022
Q4
$1.66M Buy
21,615
+21,500
+18,696% +$1.63M 0.48% 52
2022
Q3
$7K Buy
+115
New +$7.29K ﹤0.01% 292

Other funds holding CAH

Bellwether Advisors's CAH Position: Q2 2026 in Review

Bellwether Advisors reduced its Cardinal Health (CAH) stake by 33% in Q2 2026, selling an estimated $685K and leaving 6,646 shares worth $1.58M. The position accounts for 0.23% of the portfolio, ranked #78.

Bellwether Advisors first reported a position in CAH in Q3 2022 and has held it in 11 quarters since. The position peaked at $6.29M in Q4 2023. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Bellwether Advisors held 6,646 shares of Cardinal Health worth $1.58M as of Q2 2026.
  • Bellwether Advisors sold 3,294 Cardinal Health shares in Q2 2026, an estimated $685K.
  • Cardinal Health made up 0.23% of Bellwether Advisors's portfolio in Q2 2026, its #78 holding.
  • Bellwether Advisors first reported a position in Cardinal Health in Q3 2022 and has held it in 11 quarters since.
  • Bellwether Advisors's Cardinal Health position peaked at $6.29M in Q4 2023.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Bellwether Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.